{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T01:08:10Z","timestamp":1790730490146,"version":"4.1.0"},"reference-count":32,"publisher":"Walter de Gruyter GmbH","issue":"1","license":[{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,6,9]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Context<\/jats:title>\n                  <jats:p>Accumulated evidence indicates that geniposide exhibits neuroprotective effects in ischemic stroke. However, the potential targets of geniposide remain unclear.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Objective<\/jats:title>\n                  <jats:p>We explore the potential targets of geniposide in ischemic stroke.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Materials and methods<\/jats:title>\n                  <jats:p>Adult male C57BL\/6 mice were subjected to the middle cerebral artery occlusion (MCAO) model. Mice were randomly divided into five groups: Sham, MCAO, and geniposide-treated (i.p. twice daily for 3 days before MCAO) at doses of 25, 75, or 150\u2009mg\/kg. We first examined the neuroprotective effects of geniposide. Then, we further explored via biological information analysis and verified the underlying mechanism <jats:italic>in vivo<\/jats:italic> and <jats:italic>in vitro<\/jats:italic>.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results:<\/jats:title>\n                  <jats:p>In the current study, geniposide had no toxicity at concentrations of up to 150\u2009mg\/kg. Compared with the MCAO group, the 150\u2009mg\/kg group of geniposide significantly (<jats:italic>P<\/jats:italic> &lt; 0.05) improved neurological deficits, brain edema (79.00 \u00b1 0.57% vs 82.28 \u00b1 0.53%), and infarct volume (45.10 \u00b1 0.24% vs 54.73 \u00b1 2.87%) at 24\u2009h after MCAO. Biological information analysis showed that the protective effect was closely related to the inflammatory response. Geniposide suppressed interleukin-6 (IL-6) and inducible nitric oxide synthase (iNOS) expression in the brain homogenate, as measured by enzyme-linked immunosorbent assay (ELISA). Geniposide upregulated A20 and downregulated TNF receptor-associated factor-6 and nuclear factor kappa-B phosphorylation in the MCAO model and lipopolysaccharide-treated BV2 cells at 100\u2009\u03bcM.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>Geniposide exhibited a neuroprotective effect via attenuating inflammatory response, as indicated by biological information analysis, <jats:italic>in vivo<\/jats:italic> and <jats:italic>in vitro<\/jats:italic> experiments, which may provide a potential direction for the application of geniposide in the treatment of ischemic stroke.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1515\/tnsci-2022-0273","type":"journal-article","created":{"date-parts":[[2023,6,9]],"date-time":"2023-06-09T13:30:51Z","timestamp":1686317451000},"source":"Crossref","is-referenced-by-count":15,"title":["Geniposide protected against cerebral ischemic injury through the anti-inflammatory effect via the NF-\u03baB signaling pathway"],"prefix":"10.1515","volume":"14","author":[{"given":"Qian","family":"Sun","sequence":"first","affiliation":[{"name":"Department of Neurology, Second Hospital of Hebei Medical University , Shijiazhuang , Hebei, 050000 , China"},{"name":"Hebei Collaborative Innovation Center for Cardio-Cerebrovascular Disease and Hebei Key Laboratory of Vascular Homeostasis , Shijiazhuang , Hebei , China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiangjian","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Neurology, Second Hospital of Hebei Medical University , Shijiazhuang , Hebei, 050000 , China"},{"name":"Hebei Collaborative Innovation Center for Cardio-Cerebrovascular Disease and Hebei Key Laboratory of Vascular Homeostasis , Shijiazhuang , Hebei , China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingyi","family":"Fan","sequence":"additional","affiliation":[{"name":"Department of Neurology, Second Hospital of Hebei Medical University , Shijiazhuang , Hebei, 050000 , China"},{"name":"Hebei Collaborative Innovation Center for Cardio-Cerebrovascular Disease and Hebei Key Laboratory of Vascular Homeostasis , Shijiazhuang , Hebei , China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lan","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Neurology, Second Hospital of Hebei Medical University , Shijiazhuang , Hebei, 050000 , China"},{"name":"Hebei Collaborative Innovation Center for Cardio-Cerebrovascular Disease and Hebei Key Laboratory of Vascular Homeostasis , Shijiazhuang , Hebei , China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Ji","sequence":"additional","affiliation":[{"name":"Department of Neurology, Second Hospital of Hebei Medical University , Shijiazhuang , Hebei, 050000 , China"},{"name":"Hebei Collaborative Innovation Center for Cardio-Cerebrovascular Disease and Hebei Key Laboratory of Vascular Homeostasis , Shijiazhuang , Hebei , China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Xue","sequence":"additional","affiliation":[{"name":"Department of Neurology, Second Hospital of Hebei Medical University , Shijiazhuang , Hebei, 050000 , China"},{"name":"Hebei Collaborative Innovation Center for Cardio-Cerebrovascular Disease and Hebei Key Laboratory of Vascular Homeostasis , Shijiazhuang , Hebei , China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cong","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Neurology, Second Hospital of Hebei Medical University , Shijiazhuang , Hebei, 050000 , China"},{"name":"Hebei Collaborative Innovation Center for Cardio-Cerebrovascular Disease and Hebei Key Laboratory of Vascular Homeostasis , Shijiazhuang , Hebei , China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rong","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Neurology, Second Hospital of Hebei Medical University , Shijiazhuang , Hebei, 050000 , China"},{"name":"Hebei Collaborative Innovation Center for Cardio-Cerebrovascular Disease and Hebei Key Laboratory of Vascular Homeostasis , Shijiazhuang , Hebei , China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Zhao","sequence":"additional","affiliation":[{"name":"Department of Neurology, Second Hospital of Hebei Medical University , Shijiazhuang , Hebei, 050000 , China"},{"name":"Hebei Collaborative Innovation Center for Cardio-Cerebrovascular Disease and Hebei Key Laboratory of Vascular Homeostasis , Shijiazhuang , Hebei , China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junmin","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Neurology, Second Hospital of Hebei Medical University , Shijiazhuang , Hebei, 050000 , China"},{"name":"Hebei Collaborative Innovation Center for Cardio-Cerebrovascular Disease and Hebei Key Laboratory of Vascular Homeostasis , Shijiazhuang , Hebei , China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoxia","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Neurology, Second Hospital of Hebei Medical University , Shijiazhuang , Hebei, 050000 , China"},{"name":"Hebei Collaborative Innovation Center for Cardio-Cerebrovascular Disease and Hebei Key Laboratory of Vascular Homeostasis , Shijiazhuang , Hebei , China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Degang","family":"Song","sequence":"additional","affiliation":[{"name":"Department of Neurology, Second Hospital of Hebei Medical University , Shijiazhuang , Hebei, 050000 , China"},{"name":"Hebei Collaborative Innovation Center for Cardio-Cerebrovascular Disease and Hebei Key Laboratory of Vascular Homeostasis , Shijiazhuang , Hebei , China"},{"name":"Department of Neurology, First Hospital of Qinhuangdao , Hebei , China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"374","published-online":{"date-parts":[[2023,6,9]]},"reference":[{"key":"2023090109332069623_j_tnsci-2022-0273_ref_001","doi-asserted-by":"crossref","unstructured":"Chen L, Li M, Yang Z, Tao W, Wang P, Tian X, et al. Gardenia jasminoides Ellis: Ethnopharmacology, phytochemistry, and pharmacological and industrial applications of an important traditional Chinese medicine. J Ethnopharmacol. 2020;257:112829.","DOI":"10.1016\/j.jep.2020.112829"},{"key":"2023090109332069623_j_tnsci-2022-0273_ref_002","doi-asserted-by":"crossref","unstructured":"Shan M, Yu S, Yan H, Guo S, Xiao W, Wang Z, et al. A review on the phytochemistry, pharmacology, pharmacokinetics and toxicology of geniposide, a natural product. Molecules. 2017;22(10):1689.","DOI":"10.3390\/molecules22101689"},{"key":"2023090109332069623_j_tnsci-2022-0273_ref_003","doi-asserted-by":"crossref","unstructured":"Zhang R, Zhu X, Bai H, Ning K. Network pharmacology databases for traditional chinese medicine: Review and assessment. Front Pharmacol. 2019;10:123.","DOI":"10.3389\/fphar.2019.00123"},{"key":"2023090109332069623_j_tnsci-2022-0273_ref_004","doi-asserted-by":"crossref","unstructured":"Wang X, Wang ZY, Zheng JH, Li S. TCM network pharmacology: A new trend towards combining computational, experimental and clinical approaches. Chin J Nat Med. 2021;19(1):1\u201311.","DOI":"10.1016\/S1875-5364(21)60001-8"},{"key":"2023090109332069623_j_tnsci-2022-0273_ref_005","doi-asserted-by":"crossref","unstructured":"Zhao J, Zhang X, Dong L, Wen Y, Zheng X, Zhang C, et al. Cinnamaldehyde inhibits inflammation and brain damage in a mouse model of permanent cerebral ischaemia. Br J Pharmacol. 2015;172(20):5009\u201323.","DOI":"10.1111\/bph.13270"},{"key":"2023090109332069623_j_tnsci-2022-0273_ref_006","doi-asserted-by":"crossref","unstructured":"Song D, Zhang X, Chen J, Liu X, Xue J, Zhang L, et al. Wnt canonical pathway activator TWS119 drives microglial anti-inflammatory activation and facilitates neurological recovery following experimental stroke. J Neuroinflammation. 2019;16(1):256.","DOI":"10.1186\/s12974-019-1660-8"},{"key":"2023090109332069623_j_tnsci-2022-0273_ref_007","doi-asserted-by":"crossref","unstructured":"Xue J, Zhang X, Zhang C, Kang N, Liu X, Yu J, et al. Protective effect of Naoxintong against cerebral ischemia reperfusion injury in mice. J Ethnopharmacol. 2016;182:181\u20139.","DOI":"10.1016\/j.jep.2016.02.022"},{"key":"2023090109332069623_j_tnsci-2022-0273_ref_008","doi-asserted-by":"crossref","unstructured":"Zhang N, Zhang X, Liu X, Wang H, Xue J, Yu J, et al. Chrysophanol inhibits NALP3 inflammasome activation and ameliorates cerebral ischemia\/reperfusion in mice. Mediators Inflamm. 2014;2014:370530.","DOI":"10.1155\/2014\/370530"},{"key":"2023090109332069623_j_tnsci-2022-0273_ref_009","doi-asserted-by":"crossref","unstructured":"Zhang H, Zhao C, Lv C, Liu X, Du S, Li Z, et al. Geniposide alleviates amyloid-induced synaptic injury by protecting axonal mitochondrial trafficking. Front Cell Neurosci. 2016;10:309.","DOI":"10.3389\/fncel.2016.00309"},{"key":"2023090109332069623_j_tnsci-2022-0273_ref_010","doi-asserted-by":"crossref","unstructured":"Yuan J, Zhang J, Cao J, Wang G, Bai H. Geniposide alleviates traumatic brain injury in rats via anti-inflammatory effect and MAPK\/NF-kB inhibition. Cell Mol Neurobiol. 2019;40:511\u201320.","DOI":"10.1007\/s10571-019-00749-6"},{"key":"2023090109332069623_j_tnsci-2022-0273_ref_011","doi-asserted-by":"crossref","unstructured":"Yang S, Kuang G, Jiang R, Wu S, Zeng T, Wang Y, et al. Geniposide protected hepatocytes from acetaminophen hepatotoxicity by down-regulating CYP 2E1 expression and inhibiting TLR 4\/NF-kappaB signaling pathway. Int Immunopharmacol. 2019;74:105625.","DOI":"10.1016\/j.intimp.2019.05.010"},{"key":"2023090109332069623_j_tnsci-2022-0273_ref_012","doi-asserted-by":"crossref","unstructured":"Kinsella S, Fichtner M, Watters O, Konig HG, Prehn JHM. Increased A20-E3 ubiquitin ligase interactions in bid-deficient glia attenuate TLR3- and TLR4-induced inflammation. J Neuroinflammation. 2018;15(1):130.","DOI":"10.1186\/s12974-018-1143-3"},{"key":"2023090109332069623_j_tnsci-2022-0273_ref_013","doi-asserted-by":"crossref","unstructured":"Guven-Maiorov E, Keskin O, Gursoy A, Nussinov R. A structural view of negative regulation of the toll-like receptor-mediated inflammatory pathway. Biophys J. 2015;109(6):1214\u201326.","DOI":"10.1016\/j.bpj.2015.06.048"},{"key":"2023090109332069623_j_tnsci-2022-0273_ref_014","doi-asserted-by":"crossref","unstructured":"Li Y, Mooney EC, Holden SE, Xia XJ, Cohen DJ, Walsh SW, et al. A20 orchestrates inflammatory response in the oral mucosa through restraining NF-kappaB activity. J Immunol. 2019;202(7):2044\u201356.","DOI":"10.4049\/jimmunol.1801286"},{"key":"2023090109332069623_j_tnsci-2022-0273_ref_015","doi-asserted-by":"crossref","unstructured":"Voet S, Mc Guire C, Hagemeyer N, Martens A, Schroeder A, Wieghofer P, et al. A20 critically controls microglia activation and inhibits inflammasome-dependent neuroinflammation. Nat Commun. 2018;9(1):2036.","DOI":"10.1038\/s41467-018-04376-5"},{"key":"2023090109332069623_j_tnsci-2022-0273_ref_016","doi-asserted-by":"crossref","unstructured":"Sunaga K, Sugaya E, Kajiwara K, Tsuda T, Sugaya A, Kimura M. Molecular mechanism of preventive effect of peony root extract on neuron damage. J Herb Pharmacother. 2004;4(1):9\u201320.","DOI":"10.1080\/J157v04n01_02"},{"key":"2023090109332069623_j_tnsci-2022-0273_ref_017","doi-asserted-by":"crossref","unstructured":"Zhang L, Zhang X, Zhang C, Bai X, Zhang J, Zhao X, et al. Nobiletin promotes antioxidant and anti-inflammatory responses and elicits protection against ischemic stroke in vivo. Brain Res. 2016;1636:130\u201341.","DOI":"10.1016\/j.brainres.2016.02.013"},{"key":"2023090109332069623_j_tnsci-2022-0273_ref_018","doi-asserted-by":"crossref","unstructured":"Longa EZ, Weinstein PR, Carlson S, Cummins R. Reversible middle cerebral artery occlusion without craniectomy in rats. Stroke. 1989;20(1):84\u201391.","DOI":"10.1161\/01.STR.20.1.84"},{"key":"2023090109332069623_j_tnsci-2022-0273_ref_019","doi-asserted-by":"crossref","unstructured":"Ji H, Zhang X, Du Y, Liu H, Li S, Li L. Polydatin modulates inflammation by decreasing NF-kappaB activation and oxidative stress by increasing Gli1, Ptch1, SOD1 expression and ameliorates blood-brain barrier permeability for its neuroprotective effect in pMCAO rat brain. Brain Res Bull. 2012;87(1):50\u20139.","DOI":"10.1016\/j.brainresbull.2011.09.021"},{"key":"2023090109332069623_j_tnsci-2022-0273_ref_020","doi-asserted-by":"crossref","unstructured":"Zhang J, Fu B, Zhang X, Chen L, Zhang L, Zhao X, et al. Neuroprotective effect of bicyclol in rat ischemic stroke: down-regulates TLR4, TLR9, TRAF6, NF-kappaB, MMP-9 and up-regulates claudin-5 expression. Brain Res. 2013;1528:80\u20138.","DOI":"10.1016\/j.brainres.2013.06.032"},{"key":"2023090109332069623_j_tnsci-2022-0273_ref_021","doi-asserted-by":"crossref","unstructured":"Xue J, Yu Y, Zhang X, Zhang C, Zhao Y, Liu B, et al. Sphingomyelin synthase 2 inhibition ameliorates cerebral ischemic reperfusion injury through reducing the recruitment of toll-like receptor 4 to lipid rafts. J Am Heart Assoc. 2019;8(22):e012885.","DOI":"10.1161\/JAHA.119.012885"},{"key":"2023090109332069623_j_tnsci-2022-0273_ref_022","doi-asserted-by":"crossref","unstructured":"Zhou YX, Zhang RQ, Rahman K, Cao ZX, Zhang H, Peng C. Diverse pharmacological activities and potential medicinal benefits of geniposide. Evid Based Complement Alternat Med. 2019;2019:4925682.","DOI":"10.1155\/2019\/4925682"},{"key":"2023090109332069623_j_tnsci-2022-0273_ref_023","doi-asserted-by":"crossref","unstructured":"Xu B, Li YL, Xu M, Yu CC, Lian MQ, Tang ZY, et al. Geniposide ameliorates TNBS-induced experimental colitis in rats via reducing inflammatory cytokine release and restoring impaired intestinal barrier function. Acta Pharmacol Sin. 2017;38(5):688\u201398.","DOI":"10.1038\/aps.2016.168"},{"key":"2023090109332069623_j_tnsci-2022-0273_ref_024","doi-asserted-by":"crossref","unstructured":"Liu J, Yin F, Zheng X, Jing J, Hu Y. Geniposide, a novel agonist for GLP-1 receptor, prevents PC12 cells from oxidative damage via MAP kinase pathway. Neurochem Int. 2007;51(6\u20137):361\u20139.","DOI":"10.1016\/j.neuint.2007.04.021"},{"key":"2023090109332069623_j_tnsci-2022-0273_ref_025","doi-asserted-by":"crossref","unstructured":"Zhang Y, Ding Y, Zhong X, Guo Q, Wang H, Gao J, et al. Geniposide acutely stimulates insulin secretion in pancreatic beta-cells by regulating GLP-1 receptor\/cAMP signaling and ion channels. Mol Cell Endocrinol. 2016;430:89\u201396.","DOI":"10.1016\/j.mce.2016.04.020"},{"key":"2023090109332069623_j_tnsci-2022-0273_ref_026","doi-asserted-by":"crossref","unstructured":"Zhao C, Zhang H, Li H, Lv C, Liu X, Li Z, et al. Geniposide ameliorates cognitive deficits by attenuating the cholinergic defect and amyloidosis in middle-aged Alzheimer model mice. Neuropharmacology. 2017;116:18\u201329.","DOI":"10.1016\/j.neuropharm.2016.12.002"},{"key":"2023090109332069623_j_tnsci-2022-0273_ref_027","doi-asserted-by":"crossref","unstructured":"McBride DW, Zhang JH. Precision Stroke animal models: the permanent MCAO model should be the primary model, not transient MCAO. Transl Stroke Res. 2017;8:397\u2013404.","DOI":"10.1007\/s12975-017-0554-2"},{"key":"2023090109332069623_j_tnsci-2022-0273_ref_028","doi-asserted-by":"crossref","unstructured":"Shi K, Tian DC, Li ZG, Ducruet AF, Lawton MT, Shi FD. Global brain inflammation in stroke. Lancet Neurol. 2019;18(11):1058\u201366.","DOI":"10.1016\/S1474-4422(19)30078-X"},{"key":"2023090109332069623_j_tnsci-2022-0273_ref_029","doi-asserted-by":"crossref","unstructured":"Otxoa-de-Amezaga A, Miro-Mur F, Pedragosa J, Gallizioli M, Justicia C, Gaja-Capdevila N, et al. Microglial cell loss after ischemic stroke favors brain neutrophil accumulation. Acta Neuropathol. 2019;137(2):321\u201341.","DOI":"10.1007\/s00401-018-1954-4"},{"key":"2023090109332069623_j_tnsci-2022-0273_ref_030","doi-asserted-by":"crossref","unstructured":"Di Lucente J, Nguyen HM, Wulff H, Jin LW, Maezawa I. The voltage-gated potassium channel Kv1.3 is required for microglial pro-inflammatory activation in vivo. Glia. 2018;66(9):1881\u201395.","DOI":"10.1002\/glia.23457"},{"key":"2023090109332069623_j_tnsci-2022-0273_ref_031","doi-asserted-by":"crossref","unstructured":"Du J, Nicolaes GA, Kruijswijk D, Versloot M, van der Poll T, van 't Veer C. The structure function of the death domain of human IRAK-M. Cell Commun Signal. 2014;12:77.","DOI":"10.1186\/s12964-014-0077-3"},{"key":"2023090109332069623_j_tnsci-2022-0273_ref_032","doi-asserted-by":"crossref","unstructured":"Liu S, Zheng M, Li Y, He L, Chen T. The protective effect of geniposide on diabetic cognitive impairment through BTK\/TLR4\/NF-kappaB pathway. Psychopharmacology (Berl). 2020;237(2):465\u201377.","DOI":"10.1007\/s00213-019-05379-w"}],"container-title":["Translational Neuroscience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.degruyter.com\/document\/doi\/10.1515\/tnsci-2022-0273\/xml","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.degruyter.com\/document\/doi\/10.1515\/tnsci-2022-0273\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T09:42:14Z","timestamp":1693561334000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.degruyter.com\/document\/doi\/10.1515\/tnsci-2022-0273\/html"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1,1]]},"references-count":32,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,8,18]]},"published-print":{"date-parts":[[2023,8,18]]}},"alternative-id":["10.1515\/tnsci-2022-0273"],"URL":"https:\/\/doi.org\/10.1515\/tnsci-2022-0273","relation":{},"ISSN":["2081-6936"],"issn-type":[{"value":"2081-6936","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,1,1]]},"article-number":"20220273"}}